Anti-inflammatory drug delivery from hyaluronic acid hydrogels.
Two different types of hyaluronic acid (HA) hydrogels were synthesized by crosslinking HA with divinyl sulfone (DVS) and poly(ethylene glycol)-divinyl sulfone (VS-PEG-VS). Vitamin E succinate (VES), an anti-inflammatory drug, and bovine serum albumin (BSA), a model of anti-inflammatory protein drugs, were loaded into the gels and their release kinetics were measured in vitro. VES and BSA released with a burst from both HA hydrogels during the first few hours, and release continued gradually for several days. The rate of release from HA-VS-PEG-VS-HA hydrogels was faster than that from HA-DVS-HA hydrogels, presumably due to the lower crosslink density in the former. The anti-inflammatory action of released VES was tested by incubating peripheral blood mononuclear cells (PBMC) on HA hydrogels with and without VES in the gel. The number of cells adhering on HA hydrogels was very low compared to that on tissue culture polystyrene (TCPS), which might be one of the important advantages of using HA hydrogels for implant coatings or tissue engineering applications. ELISA test results showed that the tumor necrosis factor-alpha (TNF-alpha) concentration was very low in the supernatant of the wells containing the HA hydrogel with VES in contact with the activated macrophages compared to that without VES. This is probably the effect of the released VES reducing the production of anti-inflammatory cytokine, TNF-alpha. HA hydrogels containing anti-inflammatory drugs may have potential for use in tissue engineering and also as biocompatible coatings of implants.
Hahn
Sei K
SK
Department of Bioengineering, University of Washington, Seattle, WA 98195, USA. sekanhn@chugai-pharm.co.jp
Jelacic
Sandra
S
Maier
Ronald V
RV
Stayton
Patrick S
PS
Hoffman
Allan S
AS
D000818:Animals; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000008:administration & dosage*; D001672:Biocompatible Materials / Q000138:chemical synthesis* / Q000737:chemistry; D002417:Cattle; D003432:Cross-Linking Reagents; D016503:Drug Delivery Systems; D006801:Humans; D006820:Hyaluronic Acid / Q000737:chemistry; D020100:Hydrogels / Q000138:chemical synthesis* / Q000737:chemistry; D066298:In Vitro Techniques; D008262:Macrophage Activation; D008422:Materials Testing; D008855:Microscopy, Electron, Scanning; D015394:Molecular Structure; D011092:Polyethylene Glycols / Q000138:chemical synthesis / Q000737:chemistry; D012710:Serum Albumin, Bovine / Q000008:administration & dosage; D013450:Sulfones / Q000737:chemistry; D024505:Tocopherols; D014810:Vitamin E / Q000008:administration & dosage / Q000031:analogs & derivatives*
D000894:Anti-Inflammatory Agents, Non-Steroidal; D001672:Biocompatible Materials; D003432:Cross-Linking Reagents; D020100:Hydrogels; D013450:Sulfones; D014810:Vitamin E; D012710:Serum Albumin, Bovine; D011092:Polyethylene Glycols; C009873:divinyl sulfone; D006820:Hyaluronic Acid; D024505:Tocopherols